-+ 0.00%
-+ 0.00%
-+ 0.00%

Xenon Pharmaceuticals director Steven Gannon disposes of 10,000 common shares for $640,550

PUBT·08/13/2026 20:42:18
Listen to the news
Xenon Pharmaceuticals director Steven Gannon disposes of 10,000 common shares for $640,550
  • Xenon Pharmaceuticals director Steven Gannon sold 10,000 common shares on Aug. 11, 2026 at a weighted-average price of $64.06.
  • Gannon’s direct holding fell to 1,870 common shares following the sale.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xenon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-349351), on August 13, 2026, and is solely responsible for the information contained therein.